Related Experiment Videos
Parkinsonism as a manifestation of multiple sclerosis
Silvia Folgar1, Emilia Mabel Gatto, Gabriela Raina
1Movement Disorders and Parkinson's Disease Program, Institute of Neurosciences, Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.
Abstract:
We describe a 48-year-old patient, with a diagnosis of relapsing-remitting multiple sclerosis, who presented to our service with a parkinsonian syndrome that markedly improved after corticosteroid treatment. To the best of our knowledge, only 12 cases of parkinsonism have been reported from 1970 to the present, of which only 8 seemed secondary to MS, i.e., those presenting conclusive imaging evidence or unequivocal response to corticosteroids.
Insights
A patient with multiple sclerosis (MS) experienced parkinsonism that significantly improved with corticosteroid therapy. This rare presentation highlights a potential link between MS and parkinsonian syndromes, particularly those responsive to steroids.
Area of Science:
- Neurology
- Neuroimmunology
- Clinical Neuroscience
Background:
- Relapsing-remitting multiple sclerosis (RRMS) is a chronic autoimmune disease affecting the central nervous system.
- Parkinsonism is a neurological disorder characterized by tremors, rigidity, and bradykinesia, typically associated with neurodegenerative conditions.
- The co-occurrence of multiple sclerosis and parkinsonism is exceptionally rare.
Observation:
- A 48-year-old patient diagnosed with RRMS presented with a distinct parkinsonian syndrome.
- The patient's parkinsonian symptoms showed a remarkable and rapid improvement following treatment with corticosteroids.
- This clinical response suggests a potential inflammatory or immune-mediated etiology for the observed parkinsonism in the context of MS.
Findings:
- This case represents one of a limited number of reported instances of parkinsonism associated with multiple sclerosis.
- The patient's clear response to corticosteroid therapy strongly supports the hypothesis that this parkinsonism was secondary to MS.
- Conclusive imaging evidence or a definitive response to corticosteroids are key indicators for MS-related parkinsonism.
Implications:
- This case underscores the importance of considering neuroinflammatory processes in atypical presentations of parkinsonism.
- Further research into the mechanisms linking MS and parkinsonism may reveal novel therapeutic targets.
- Early recognition and appropriate treatment of steroid-responsive parkinsonism in MS patients can lead to significant clinical improvement.